Indian Healthcare

  • Ranbaxy case: Should Indian patients worry over sub-standard drugs? 05-06-2013 02:26 PM

    Mumbai: India exports drugs worth more than 15 billion dollars every year, a majority of which are US-bound. Questions are being raised about the standards and quality, after Ranbaxy's whopping 500 million dollar settlement with the US government. The generic drugs in question were manufactured at Ranbaxy's plants in Paonta...